Search filters

List of works by Alexandria P. Cogdill

Affinity-Tuned ErbB2 or EGFR Chimeric Antigen Receptor T Cells Exhibit an Increased Therapeutic Index against Tumors in Mice

scientific article

Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy

scientific article published on 15 June 2022

B cells and tertiary lymphoid structures promote immunotherapy response

scientific article published on 15 January 2020

BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma.

scientific article published on 10 January 2013

COT drives resistance to RAF inhibition through MAP kinase pathway reactivation

scientific article (publication date: 16 December 2010)

Checkpoint Blockade Reverses Anergy in IL-13Rα2 Humanized scFv-Based CAR T Cells to Treat Murine and Canine Gliomas

scientific article published on 28 August 2018

Combination anti-CTLA-4 plus anti-PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies

scientific article published on 21 October 2019

Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells

scientific article published in Nature

Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade

scientific article published on 9 August 2017

EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF-Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib

scientific article published on January 16, 2012

Elucidating the gut microbiota composition and the bioactivity of immunostimulatory commensals for the optimization of immune checkpoint inhibitors

scientific article published on 20 July 2020

Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma

scientific article published on June 2016

Gene Targeting Meets Cell-Based Therapy: Raising the Tail, or Merely a Whimper?

scientific article published on 11 November 2016

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

scientific article

Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma.

scientific article

Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.

scientific article published on 2 November 2017

Hallmarks of response to immune checkpoint blockade

scientific article

Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia

scientific article published on 26 January 2016

Immunodynamics of explanted human tumors for immuno-oncology

scientific article published on 29 December 2020

Potential role of 5-aza-2'-deoxycytidine induced MAGE-A4 expression in immunotherapy for anaplastic thyroid cancer

scientific article published on December 2013

Rational development and characterization of humanized anti-EGFR variant III chimeric antigen receptor T cells for glioblastoma

scientific article published on February 2015

Targeting the MAGE A3 antigen in pancreatic cancer

scientific article published on July 6, 2012

The Impact of Intratumoral and Gastrointestinal Microbiota on Systemic Cancer Therapy

scientific article published on 01 November 2018

The Rationale and Emerging Use of Neoadjuvant Immune Checkpoint Blockade for Solid Malignancies.

scientific article published on 2 March 2018

The human tumor microbiome is composed of tumor type-specific intracellular bacteria

scientific article